The reawakening of a sleeping little giant

Emergency Medicine Journal

Volumn 22, Issue 5, 2005, Pages 384-386

  Goddard, Robert ^a  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE; FLUCLOXACILLIN; METRONIDAZOLE; PENICILLIN G;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CELLULITIS; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIARRHEA; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EYE DISEASE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH SERVICE; HERPES ZOSTER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICAL SPECIALIST; MOUTHWASH; PATIENT TRANSPORT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT FAILURE; TRIGEMINAL NERVE DISEASE; VARICELLA ZOSTER VIRUS; VOMITING;

AGED; AGED, 80 AND OVER; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMANS; MALE; MOUTH DISEASES; TRIGEMINAL NERVE DISEASES;

EID: 18744415204     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2003.008656     Document Type: Article

References (11)

1. Bajwa ZH, Ho CC. Herpetic neuralgia: use of combination therapy for pain relief in acute and chronic herpes zoster. Geriatrics 2001;56:18-24.
2. Cunningham A, Dworkin R. The management of post-herpetic neuralgia. BMJ 2000;321:778-9.
3. Torrens J, Nathwani D, MacDonald T, et al. Acute Herpes zoster in Tayside: demographic and treatment details in immunocompetent patients 1989-1992. J Infect 1998; 36:209-14.
4. Edmunds WJ, Brisson M, Rose JD, et al. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 2001;19:3076-90.
5. Brisson M, Edmunds WJ, Gay NJ, et al. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 2000;18:2775-8.
6. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996;10:571-81.
7. Trannoy E, Berger R, Hollander G, et al. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine 2000;18:1700-6.
8. Goh CL, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 1997;36:667-72.
9. Gnann JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347:340-6.
10. Gnann JW. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002; 186(suppl 1):S91-8.
11. Stankus SJ, et al. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 2000; 1:2437-44, 2447-8.